Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Rev Esp Anestesiol Reanim ; 59(3): 142-9, 2012 Mar.
Article in Spanish | MEDLINE | ID: mdl-22985755

ABSTRACT

OBJECTIVES: There is a high incidence of pulmonary hypertension during the lung transplant peri-operative period, and could lead to a haemodynamic deterioration that may require the need of extracorporeal circulation. Our aim was to study the haemodynamic effects on the pulmonary and systemic circulation of the combination of inhaled nitric oxide and iloprost and oral sildenafil in patients with severe pulmonary hypertension during lung transplant surgery. PATIENTS AND METHODS: Seventeen patients received 10µg of nebulised iloprost during the peri-operative period of the lung transplant when their mean pulmonary pressure exceeded 50mmHg. AU the patients received 50mg of oral sildenafil 30min before anaesthetic induction, 20ppm of inhaled nitric oxide after tracheal intubation. The haemodynamic and respiratory variables were recorded at baseline (after anaesthetic induction), prior to the administering of iloprost, and at 5 and 30min after it was given. RESULTS: The administering of iloprost significantly reduced the pulmonary arterial pressure and significantly increases the cardiac Índex and the right ventrícular ejection fractíon. There were no signíficant changes occurred in the systemic arterial pressure. CONCLUSIONS: The triple combination significantly reduces the pulmonary pressures in the lung transplant peri-operative and should be considered when there is severe pulmonary hypertension during the surgery or during the immediate post-operative period of lung transplantation.


Subject(s)
Hypertension, Pulmonary/drug therapy , Iloprost/administration & dosage , Intraoperative Complications/drug therapy , Lung Transplantation , Nitric Oxide/administration & dosage , Piperazines/administration & dosage , Sulfones/administration & dosage , Vasodilator Agents/administration & dosage , Administration, Inhalation , Administration, Oral , Adult , Aged , Cystic Fibrosis/surgery , Dobutamine/administration & dosage , Drug Therapy, Combination , Female , Hemodynamics , Humans , Hypertension, Pulmonary/etiology , Iloprost/therapeutic use , Male , Middle Aged , Nebulizers and Vaporizers , Nitric Oxide/therapeutic use , Norepinephrine/administration & dosage , Piperazines/therapeutic use , Preoperative Care , Prospective Studies , Pulmonary Disease, Chronic Obstructive/surgery , Purines/administration & dosage , Purines/therapeutic use , Sildenafil Citrate , Sulfones/therapeutic use , Treatment Outcome , Vasodilator Agents/therapeutic use
2.
Rev. esp. anestesiol. reanim ; 59(3): 142-149, mar. 2012.
Article in Spanish | IBECS | ID: ibc-100355

ABSTRACT

Objetivos: La presencia de hipertensión pulmonar tiene elevada incidencia durante el perioperatorio del trasplante pulmonar y puede condicionar deterioro hemodinámico que obligue a instaurar circulación extracorpórea. Nuestro objetivo es estudiar los efectos hemodinámicos en la circulación pulmonar y sistémica de la asociación de óxido nítrico e iloprost inhalados y sildenafilo por vía oral en pacientes con hipertensión pulmonar severa durante la cirugía de trasplante pulmonar. Pacientes y métodos: Durante el perioperatorio del trasplante pulmonar, 17 pacientes recibieron 10 mg de iloprost nebulizado cuando su presión arterial pulmonar media superó los 50 mmHg. Todos los pacientes recibieron 50 mg de sildenafilo por vía oral 30 min antes de la inducción anestésica y 20 ppm de NO inhalado tras la intubación traqueal. Se registraron las variables hemodinámicas y respiratorias en los tiempos basal (tras la inducción anestésica), previamente a la administración de iloprost, y a los 5 y 30 min de su administración. Resultados: La administración de iloprost redujo de forma significativa la presión arterial pulmonar e incrementó significativamente el índice cardiaco y la fracción de eyección del ventrículo derecho. No se produjeron modificaciones significativas de la presión arterial sistémica. Conclusiones: La triple asociación reduce significativamente las presiones pulmonares en el perioperatorio del trasplante pulmonar y debe considerarse en presencia de hipertensión pulmonar severa durante la intervención quirúrgica o el postoperatorio inmediato del trasplante pulmonar(AU)


Objectives: There is a high incidence of pulmonary hypertension during the lung transplant peri-operative period, and could lead to a haemodynamic deterioration that may require the need of extracorporeal circulation. Our aim was to study the haemodynamic effects on the pulmonary and systemic circulation of the combination of inhaled nitric oxide and iloprost and oral sildenafil in patients with severe pulmonary hypertension during lung transplant surgery. Patients and methods: Seventeen patients received 10mg of nebulised iloprost during the peri-operative period of the lung transplant when their mean pulmonary pressure exceeded 50 mmHg. All the patients received 50 mg of oral sildenafil 30 min before anaesthetic induction, 20 ppm of inhaled nitric oxide after tracheal intubation. The haemodynamic and respiratory variables were recorded at baseline (after anaesthetic induction), prior to the administering of iloprost, and at 5 and 30 min after it was given. Results: The administering of iloprost significantly reduced the pulmonary arterial pressure and significantly increases the cardiac index and the right ventricular ejection fraction. There were no significant changes occurred in the systemic arterial pressure. Conclusions: The triple combination significantly reduces the pulmonary pressures in the lung transplant peri-operative and should be considered when there is severe pulmonary hypertension during the surgery or during the immediate post-operative period of lung transplantation(AU)


Subject(s)
Humans , Male , Female , Iloprost/metabolism , Iloprost/pharmacokinetics , Iloprost/therapeutic use , Nitric Oxide/therapeutic use , Lung Transplantation/methods , Hypertension, Pulmonary/diagnosis , Hypertension, Pulmonary/surgery , Anesthesia/methods , Anesthesia , Adjuvants, Anesthesia/therapeutic use , Hypertension, Pulmonary/drug therapy , Monitoring, Intraoperative/instrumentation , Treatment Outcome , Lung Transplantation , Evaluation of the Efficacy-Effectiveness of Interventions
4.
Arch Bronconeumol ; 34(4): 184-8, 1998 Apr.
Article in Spanish | MEDLINE | ID: mdl-9611652

ABSTRACT

Spontaneous pneumothorax is a relatively frequent complication of human immunodeficiency virus (HIV) infection. Seven hundred sixty-five HIV-infected inpatients were treated at Marques de Valdecilla University Hospital between 1990 and 1996. Spontaneous pneumothorax developed in 9 patients. Pneumocystis carinii pneumonia was diagnosed in 6 patients (66%), either before or simultaneous to the appearance of pneumothorax. Pneumothorax was related to active or old tuberculosis infection in 3 patients (33%). Prophylactic therapy with nebulized pentamidine was used in 55% of the patients. Successful initial control of pneumothorax was achieved with simple drains in 58% of the episodes, although the recurrence rate was 71%. Pleurodesis with talcum with a chest tube was used successfully in 3 patients, in 2 because of sings of persistent air leakage uncorrected by simple drainage. Pleurodesis initially failed but later controlled pneumothorax the second time it was used. The mortality rate in this series was 66%, with a mean survival time of 55.6 days. We conclude that spontaneous pneumothorax is associated with poor prognosis in HIV infected patients. Prior or concurrent P. carinni pneumonia or tuberculosis were the etiologic factors identified in our patients. A simple pleural drain was associated with a high rate of recurrence, such that pleurodesis seems warranted in all patients.


Subject(s)
HIV Infections/complications , Pneumothorax/etiology , AIDS-Related Opportunistic Infections/complications , Adult , Anti-Infective Agents/administration & dosage , Drainage , Female , HIV Seropositivity/complications , Humans , Male , Middle Aged , Nebulizers and Vaporizers , Pentamidine/administration & dosage , Pleurodesis , Pneumonia, Pneumocystis/complications , Pneumothorax/therapy , Prognosis , Recurrence , Substance Abuse, Intravenous/complications , Talc/administration & dosage , Tuberculosis, Pulmonary/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...